CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

被引：1

作者：

Liu, Wei ^{[1
]}

Huang, Wenyang ^{[1
]}

Lv, Rui ^{[1
]}

Liu, Huimin ^{[1
]}

Yi, Shuhua ^{[1
]}

Liu, Hong ^{[1
]}

Lv, Lulu ^{[2
]}

Qiu, Lugui ^{[1
]}

Wang, Jianxiang ^{[1
]}

Zou, Dehui ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,State Key Lab Expt Hematol, Tianjin, Peoples R China

[2] Juventas Cell Therapy Ltd, Tianjin, Peoples R China

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-167104

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4598 / 4599

页数：2

共 50 条

[31] CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report
Chen, Liting
Xu, Bin
Liu, Wanying
Wang, Di
Xu, Jinhuan
Mao, Xia
Xiao, Min
Zhou, Jianfeng
Xiao, Yi
ONCOTARGETS AND THERAPY, 2022, 15 : 361 - 366
[32] Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
Vercellino, Laetitia
Di Blasi, Roberta
Kanoun, Salim
Tessoulin, Benoit
Rossi, Cedric
D'Aveni-Piney, Maud
Oberic, Lucie
Bodet-Milin, Caroline
Bories, Pierre
Olivier, Pierre
Lafon, Ingrid
Berriolo-Riedinger, Alina
Galli, Eugenio
Bernard, Sophie
Rubio, Marie-Therese
Bossard, Celine
Meignin, Veronique
Merlet, Pascal
Feugier, Pierre
Le Gouill, Steven
Ysebaert, Loic
Casasnovas, Olivier
Meignan, Michel
Chevret, Sylvie
Thieblemont, Catherine
BLOOD ADVANCES, 2020, 4 (22) : 5607 - 5615
[33] Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
Liu, Ying
Deng, Biping
Hu, Bo
Zhang, Wenqun
Zhu, Qing
Liu, Yang
Wang, Shan
Zhang, Pei
Yang, Ying
Yang, Junhan
Zheng, Qinlong
Yu, Xinjian
Gao, Zifen
Zhou, Chunju
Han, Wei
Yang, Jing
Jin, Ling
Tong, Chunrong
Chang, Alex H.
Zhang, Yonghong
BLOOD ADVANCES, 2022, 6 (03) : 717 - 730
[34] Outcomes with loncastuximab tesirine following CAR T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma
Narendranath Epperla
Melanie Lucero
Tom Bailey
Laura Mirams
Jolenta Cheung
Mona Amet
Gary Milligan
Lei Chen
Blood Cancer Journal, 14 (1)
[35] Allogeneic Transplant As a Curative Option for Relapsed/Refractory Large B-Cell Lymphoma in the Era of CAR T-Cell Therapy: A Monocentric Retrospective Study
Roche, Pauline
Brisou, Gabriel
Furst, Sabine
Noel, Robin
De Oca, Catalina Montes
Collignon, Aude
Inchiappa, Luca
De Colella, Jean Marc Schiano
Rossi, Isabelle Brenot
Reichert, Thibaut
Thevenet, Sophie
Mfarrej, Bechara
Calmels, Boris
Blaise, Didier
Chabannon, Christian
Devillier, Raynier
BLOOD, 2022, 140 : 7740 - 7741
[36] Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Cordeiro, Ana Costa
Durisek, George
Batista, Marjorie Vieira
Schmidt, Jayr
de Lima, Marcos
Bezerra, Evandro
FRONTIERS IN ONCOLOGY, 2024, 14
[37] CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) - the Munich Real Life Experience
Buecklein, V.
Schmidt, C.
Blumenberg, V.
Reischer, A.
von, Baumgarten L.
Voelkl, A.
Wagner, B.
Humpe, A.
Reilich, S.
Bauer, M.
Ostermann, H.
Tischer, J.
Stemmler, H-J.
von Bergwelt, M.
Subklewe, M.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 80 - 81
[38] KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Wang, Michael
Munoz, Javier
Goy, Andre
Locke, Frederick L.
Jacobson, Caron A.
Hill, Brian T.
Timmerman, John M.
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian W.
McSweeney, Peter A.
Miklos, David B.
Pagel, John M.
Kersten, Marie-Jose
Milpied, Noel
Fung, Henry
Topp, Max S.
Houot, Roch
Beitinjaneh, Amer
Peng, Weimin
Zheng, Lianqing
Rossi, John M.
Jain, Rajul K.
Rao, Arati V.
Reagan, Patrick M.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1331 - 1342
[39] Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
Wang, Na
Hu, Xuelian
Cao, Wenyue
Li, Chunrui
Xiao, Yi
Cao, Yang
Gu, Chaojiang
Zhang, Shangkun
Chen, Liting
Cheng, Jiali
Wang, Gaoxiang
Zhou, Xiaoxi
Zheng, Miao
Mao, Xia
Jiang, Lijun
Wang, Di
Wang, Qiuxiang
Lou, Yaoyao
Cai, Haodong
Yan, Dandan
Zhang, Yicheng
Zhang, Tongcun
Zhou, Jianfeng
Huang, Liang
BLOOD, 2020, 135 (01) : 17 - 27
[40] Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy
Perrone, Salvatore
Lopedote, Paolo
Levis, Mario
Di Rocco, Alice
Smith, Stephen Douglas
EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 215 - 232

← 1 2 3 4 5 →